Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gefitinib|DRUG: tamoxifen citrate|DRUG: Placebo
Sponsor: Dartmouth-Hitchcock Medical Center
Collaborators: National Cancer Institute (NCI)|Norris Cotton Cancer Center